Urinary angiotensinogen concentration adequately reflects the activity of the kidney pool of renin-angiotensin-aldosterone system (RAAS). Experimental and clinical studies allow considering this indicant as a reliable early marker of cardio-renal syndrome, reflecting the formation and progression of kidney damage and characterizing the effectiveness of RAAS blockers.

Keywords: diagnostic marker, cardiorenal syndrome, urine, angiotensinogen